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392* Preliminary results of motivation program for CF patients
“LifeClubCF”
M. Krzyzanowski1, M. Mikos1, P. Wojtowicz2, D. Kaminiarczyk1, W. Cichy1.
1Pediatric Gastroenterology and Metabolic Diseases, University of Medical
Sciences, Poznan, Poland; 2Foundation for helping the CF Sufferers and their
Families “MATIO”, Krakow, Poland
Aims: To increase treatment compliance and promote healthy activities among
patients with CF, decrease treatment rejection and increase regular, multidisciplinary
outpatient care attendance.
Methods: Participants of motivation program for CF patients LifeClubCF collected
points for gaining body mass, conducting physical exercise, visiting the CF outpa-
tient care, the psychologist, dietician and a physiotherapist, for regular drug intake
and for reducing the number of exacerbations. After half a year a total of 28
participants returned ﬁlled in questionnaires.
Results: The participants stayed in the program for 9 to 18 months depending on
their will. 100% of participants agreed that the program is interesting and necessary.
It was possible to exchange the collected points for rewards: mobile phones, digital
cameras, laptops and others. Comparing the periods before and 6 months after
taking part in the program, the participants visit more regularly: physiotherapist –
12 (42.86%)/21 (75%), p = 0.009 and a dietician – 10 (35.71%)/16 (57.14%),
p = 0.029. Differences in other answers were not statistically signiﬁcant. The general
drug intake before and after program does not differ.
Conclusions: Early data suggest that patients with CF showed an interest in
participating in the motivation program LifeClubCF organized by the “MATIO”
Foundation in Poland and found it useful. In terms of the disease control, it resulted
in increased frequency of physiotherapist and dietician consultations. Such program
would be especially useful in countries where the complex CF care is yet to be
developed. More detailed analysis will require further study on a bigger group.
393 Complex CF facultative classes at the University of Medical
Sciences, Poznan, Poland
M. Krzyzanowski, M. Mikos, W. Cichy. Pediatric Gastroenterology and Metabolic
Diseases, University of Medical Sciences, Poznan, Poland
Cystic Fibrosis knowledge questionnaires ﬁlled-in by students of the Poznan
University of Medical Sciences in 2004 showed that 63 out of 105 (60%) students
expressed a desire to extend their knowledge of CF. In June 2005, The Medical
Faculty board of University of Medical Sciences in Poznan, Poland agreed to start
CF facultative classes. A total of 40−60 students working in small groups of 4−10
people are educated each year in the CF domain.
Aims: Increasing the knowledge about cystic ﬁbrosis among students of The
Medical Faculty of Poznan University of Medical Sciences in Poland.
Methods: Special facultative classes at The Medical Faculty were organized.
The lectures were given by specialists of different science institutes and covered
following aspects of CF: pulmonology, gastroenterology, laryngology, genetics,
adults care, psychology, nutrition, metabolic disorders, rules of CF complex care
and Polish non-governmental CF activity. All students who attended facultative
classes received educational materials about CF.
Results: During the ﬁrst year of CF facultative classes 53 medical were educated
in the CF ﬁeld. 27 of them took part in the evaluation. The average assessment
score was 8.69 in 1−10 scale. All of the lecturers received good marks in terms of
preparation (5.31), clarity (5.43), and absorption (5.36) of the presented subject in
1−6 scale.
Conclusions: CF facultative classes are an alternative way to improve CF knowl-
edge among medical students. Almost two years of increasing interest along with
good results of the evaluation show a very positive response from the students.
These classes could play an important role in the introduction of complex and
multidisciplinary CF care to future medical doctors.
394 Seroconversion after Hepatitis B (HB) and Hepatitis A (HA)
vaccination in CF patients (pts)
I. De Schutter1, E. De Wachter1, B. Hauser1, E. Anckaert2, A. Malfroot1. 1CF
Clinic, Academic Hospital AZ-VUB, Brussels, Belgium; 2Clin. Biol.; Lab of
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Introduction: Chronic liver disease (CLD) is frequently present and may be fatal
in CF. We studied the immune response to HA- and HB-vaccines in CF-pts because
it is lower in CLD-pts.
Patients/methods: Blood samples of 153 CF-pts, mean age 13.5 y, were tested
twice (time interval 1 y) by chemiluminescent microparticle immunoassay to asses
the presence of HBs-Ab and HA-IgG, and we recorded their vaccination status.
Seronegative (SN) pts for HBs-Ab and/or HA-IgG were vaccinated in between
tests with Engerix®, Havrix® or Twinrix®.
Results: 115/120 pts (95.8%) were seropositive (SP) for HBs-Ab. 59 were fully
vaccinated with Engerix® or Twinrix®. 56 had no proof of vaccination but it is
probable as childhood vaccination with catch up for 12 y olds started in Belgium in
1999. 19 pts had CLD (9 steatosis and 10 cirrhosis). 3 pts were SP at ﬁrst but SN
1 y later. 5/120 pts (4.1%) were SN twice despite full vaccination with Twinrix® or
Engerix®. 2/5 non-responders had CLD (1 steatosis, 1 liver transplant (Tx)).
82/83 pts (98.7%) were SP for HA-IgG. 59 were fully vaccinated and 2 were not. For
23 pts vaccination was unknown. 18 SP pts had CLD (9 steatosis, 8 cirrhosis, 1 liver
Tx). 1 SN and non CLD-pt remained SN despite full vaccination with Havrix®. At
present data are incomplete for HBs-Ab and HA-IgG for 33 and 70 pts.
Conclusions: The immune response to HA- and HB-vaccines is comparable in
CF-pts and healthy subjects. CF-pts are at risk for CLD and seroconversion
must be checked after vaccination. In case of failure 1−3 extra doses can be
administered to obtain seroconversion. Revaccination is unneeded after successful
primary vaccination, even when Ab-numbers become undetectable with time.
395 Genital human papillomavirus (HPV) infection and its
consequences in CF lung transplant (tx) recipients
C. Knoop1, H. Binet1, F. Buxant1, A. Vandermeeren1, J.C. Noel1, A. Malfroot2.
1Brussels Lung Transplant Group, Erasme University Hospital, Brussels, Belgium;
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HPV infection may lead to signiﬁcant morbidity in tx recipients by causing
genital/anal warts (condyloma acuminata) as well as (pre)cancerous lesions. The
objectives of this study were (1) to report on this relatively neglected phenomenon,
(2) to assess the incidence/treatment of genital/anal HPV-associated lesions in CF
lung tx recipients. The ﬁles of all 74 CF patients transplanted at our institution
between 05/1988 and 01/2007 (38 men/36 women, median age 24±7.5, range
8−45 yrs) were retrospectively reviewed. Triple maintenance immunosuppression
was administered for life. Median survival was 46.5±44.4mos (range 0–186).
9/60 sexually active patients (15%) who survived >12mos post-tx developed HPV-
associated genital/anal lesions. There were 3 men (35, 37, 41 yrs) and 6 women
(25−35 yrs). Genital/anal HPV-proven condyloma were diagnosed at 62, 90 and 97
in the men and at 14, 16, 16, 50, 53, 90mos post-tx in the women. All underwent
local treatment (cryotherapy ± laser ± topical imiquimod), 3/9 had to undergo
multiple treatments under general anesthesia. One male patient presented associated
high-grade anal dysplasia and 2 women moderate to high-grade cervical dysplasia;
one underwent conization and the other complete hysterectomy. These retrospective
data indicate that (1) genital HPV infection may cause signiﬁcant morbidity in a
notable number of CF lung tx patients, (2) data on treatment strategies have to
be accumulated and importantly, (3) the potentially protective effects of the now
available HPV vaccine(s) in adolescents before sexual activity and before tx should
be rapidly evaluated in a multi-center effort.
